DavidS.GoldfarbMD

Director, Kidney Stone Prevention Program and Professor of Medicine & Physiology, NYU Grossman School of Medicine

Telehealth Available

Overview of Dr. Goldfarb

Dr. David Goldfarb is a nephrologist in New York, NY and is affiliated with VA NY Harbor Healthcare System, Manhattan Campus and NYU Langone Hospitals. He received his medical degree from Yale University School of Medicine and has been in practice 36 years. He is experienced in cystinuria, medullary sponge kidney, nephrolithiasis, Dent disease, CKD, ESKD, COVID-19 and gout.

Office
222 East 41st Street
11th Floor
New York, NY 10017
Book by Phone212-263-5851
Is this information wrong?

Education & Training

NYU Grossman School of MedicineFellowship, Nephrology, 1985 - 1987
NYU Grossman School of Medicine (Veterans)Residency, Internal Medicine, 1981 - 1985
Yale School of MedicineClass of 1981

Certifications & Licensure

NY State Medical License 1983 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Fellow (FASN) American Society of Nephrology
Fellow, NKF National Kidney Foundation, 2014
Super Doctor SuperDoctors.com

Clinical Trials

The Effects of Sports Drinks on Urinary Lithogenicity Start of enrollment: 2006 Mar 01
Completed
Not Applicable
Rare Kidney Stone Consortium Patient Registry Start of enrollment: 2003 Jul 01
Recruiting
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers Start of enrollment: 2009 Nov 01
Completed
Not Applicable
Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes Start of enrollment: 2003 Jan 01
Completed
Effect of Diet Orange Soda on Urinary Lithogenicity Start of enrollment: 2009 Nov 01
Completed
Not Applicable
Blood Volume Analysis and Related Outcomes in Hemodialysis Start of enrollment: 2012 Jan 01
Completed
Cystine Capacity Clinical Study (CysCap) Start of enrollment: 2012 Sep 01
Completed
Health-related Quality of Life in Rare Kidney Stone Start of enrollment: 2013 Aug 01
Recruiting
Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria Start of enrollment: 2012 Jun 01
Completed
Phase 4
Prospective Research Rare Kidney Stones (ProRKS) Start of enrollment: 2016 May 01
Recruiting
Effect of Hydroxycitrate on Urine Chemistry Start of enrollment: 2018 Oct 04
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.
Ryan S Hsi, Phyllis L Yan, Joseph J Crivelli, David S Goldfarb, Vahakn Shahinian, John M Hollingsworth> ;Urology. 2022 May 8
Cystinuria: an update on pathophysiology, genetics, and clinical management
Viola D’Ambrosio, Giovanna Capolongo, David S. Goldfarb, Giovanni Gambaro, Pietro Manuel Ferraro> ;Pediatric Nephrology. 2021 Nov 23
Recommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning.
Marc Ghannoum, Ingrid Berling, Valery Lavergne, Darren M. Roberts, Taís Freire Galvão, Robert S. Hoffman, Thomas D. Nolin, Andrew Lewington, Kent Doi, Sophie Gosselin,...> ;Kidney International. 2021 Oct 1
8 citations
Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.
Andrea G. Cogal, Jennifer Arroyo, Ronak Jagdeep Shah, Kalina J. Reese, Brenna N. Walton, Laura M. Reynolds, Gabrielle N. Kennedy, Barbara M. Seide, Sarah R. Senum, Mic...> ;Kidney International Reports. 2021 Sep 8
1 citations
Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretion
Lama Nazzal, Fritz Francois, Nora Henderson, Menghan Liu, Huilin Li, Hyunwook Koh, Chan Wang, Zhan Gao, Guillermo I. Perez Perez, John R. Asplin, David S. Goldfarb, Ma...> ;Scientific Reports. 2021 Aug 12
1 citations
Challenging patient phenotypes in the management of anaemia of chronic kidney disease.
Sheena Pramod, David S. Goldfarb> ;International Journal of Clinical Practice. 2021 Aug 12
3 citations
Feasibility and Acceptability of mHealth Interventions for Managing Hyperphosphatemia in Patients Undergoing Hemodialysis.
David E. St-Jules, Kathleen Woolf, David S. Goldfarb, Mary Lou Pompeii, Huilin Li, Chan Wang, Aditya Mattoo, Zachary A. Marcum, Mary Ann Sevick> ;Journal of Renal Nutrition. 2021 Jul 1
2 citations
Plant-Based Milk Alternatives and Risk Factors for Kidney Stones and Chronic Kidney Disease
James F. Borin, John Knight, Ross P. Holmes, Shivam Joshi, David S. Goldfarb, Stacy Loeb> ;Journal of Renal Nutrition. 2021 May 24
A Report of Two Cases: Unlearning Lactic Acidosis
Sanjay R. Mohan, David S. Goldfarb, Robert S. Hoffman> ;Clinical practice and cases in emergency medicine. 2021 Apr 8
7 citations
Sodium bicarbonate therapy for acute respiratory acidosis.
Ranjeeta Chand, Erik R. Swenson, David S. Goldfarb> ;Current Opinion in Nephrology and Hypertension. 2021 Mar 1
Editorial: Controversies in nephrologic covidology.
David S. Goldfarb> ;Current Opinion in Nephrology and Hypertension. 2021 Mar 1
10 citations
Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence.
Ryan S. Hsi, Phyllis Yan, David S. Goldfarb, Ada Egbuji, Yajuan Si, Vahakn B. Shahinian, John M. Hollingsworth> ;Urology. 2021 Mar 1
3 citations
Urinary stone disease prevalence and associations in cystic fibrosis.
Jeremy F Wright, Wendy Y Craig, F L Lucas, David S. Goldfarb, Jonathan B. Zuckerman, Eric N Taylor> ;Urological Research. 2021 Feb 6
25 citations
Urine and stone analysis for the investigation of the renal stone former: a consensus conference.
James C. Williams, Giovanni Gambaro, Allen L. Rodgers, John R. Asplin, Olivier Bonny, Antonia Costa-Bauzá, Pietro Manuel Ferraro, Giovanni B. Fogazzi, Daniel Guido Fus...> ;Urological Research. 2021 Feb 1
1 citations
Assessing the effect of extracorporeal treatments for lithium poisoning.
Valery Lavergne, Marc Ghannoum, Sophie Gosselin, David S. Goldfarb, Thomas D. Nolin, Paul I. Dargan, Darren M. Roberts> ;British Journal of Clinical Pharmacology. 2021 Jan 1
Bariatric surgery in a patient with cystinuria.
Melissa R Nemati, Peter C. Harris, Andrea G. Cogal, David S. Goldfarb> ;Clinical nephrology. Case studies. 2021 Jan 1
Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City.
Nina J Caplin, Olga Zhdanova, Manish Tandon, Nathan Thompson, Dhwanil Patel, Qandeel Soomro, Fnu Ranjeeta, Leian Joseph, Jennifer Scherer, Shivam Joshi, Betty Dyal, Ha...> ;Kidney360. 2020 Dec 31
17 citations
Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement.
Brian H. Eisner, David S. Goldfarb, Michelle A. Baum, Craig B. Langman, Gary C. Curhan, Glenn M. Preminger, John C. Lieske, Gyan Pareek, Kay Thomas, Anna L. Zisman, Di...> ;Journal of Endourology. 2020 Nov 10
6 citations
Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy
Frank Modersitzki, David S. Goldfarb, Ross L Goldstein, Roger L. Sur, Kristina L. Penniston> ;Urological Research. 2020 Aug 1
81 citations
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients.
David S. Goldfarb, Judith A. Benstein, Olga Zhdanova, Elizabeth Hammer, Clay A. Block, Nina J. Caplin, Nathan Thompson, David M. Charytan> ;Clinical Journal of The American Society of Nephrology. 2020 Jun 8
1 citations
Effects of ambient temperature and humidity on kidney stone admissions in Brazil.
Sitalakshmi Iyer, David S. Goldfarb> ;Journal of Biomedical Nanotechnology. 2020 Jun 1
1 citations
Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series.
Hrafnhildur Linnet Runolfsdottir, Tzu-Ling Lin, David S. Goldfarb, John A. Sayer, Mini Michael, David Ketteridge, Peter R. Rich, Vidar O. Edvardsson, Runolfur Palsson> ;Urological Research. 2020 May 12
7 citations
Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.
Lada Beara-Lasic, Andrea G. Cogal, Kristin C. Mara, Felicity Enders, Ramila A. Mehta, Zejfa Haskic, Susan L. Furth, Howard Trachtman, Steven J. Scheinman, Dawn S. Mill...> ;Pediatric Nephrology. 2020 Apr 1
4 citations
Nephrolithiasis in women: how different from men?
Lada Beara-Lasic, David S. Goldfarb> ;Current Opinion in Nephrology and Hypertension. 2020 Mar 1
2 citations
Medical evaluation of living kidney donors with nephrolithiasis: a survey of practices in the United States
Vasishta S. Tatapudi, Frank Modersitzki, S Marineci, Michelle A. Josephson, David S. Goldfarb> ;Clinical and Experimental Nephrology. 2020 Mar 1
Join now to see all

Other

Opioid Overuse or NSAID Underuse? A Response to the Pain Guide
David Goldfarb, MD, American Journal of Kidney Diseases
https://www.doximity.com/articles/f5536f97-56ab-4efb-8c6e-3feb55264fa5
UpToDate, Wolters Kluwer Health - 2012-05-15

Press Mentions

Removal of Small, Asymptomatic Kidney Stones Cuts Relapse RiskAugust 12th, 2022
Removal of Small Asymptomatic Kidney Stones Significantly Reduces Recurrence -News ForestAugust 10th, 2022
Removing Small Asymptomatic Kidney Stones Significantly Reduces RecurrenceAugust 10th, 2022
Join now to see all

Grant Support

CystinuriaNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011

Committees

Vice-chair, American Urological Association, Medical Management of Kidney Stones 2013 - 2014

Professional Memberships

American Society of Nephrology - ASN
Fellow
American Urological Association - AUA
Member
National Kidney Foundation - NKF
Member

Hospital Affiliations

NYU Langone HospitalsNew York, New York
Veterans Affairs New York Harbor Healthcare System - New York CampusNew York, New York

Industry Relationships

Consultant, Travere2014 - Present

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Health Net Arizona HMO
Health Net Arizona PPO/POS
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment